S&P 500   3,108.33 (+0.15%)
DOW   27,855.44 (+0.32%)
QQQ   201.50 (-0.10%)
CGC   18.33 (-9.66%)
BABA   185.83 (+0.52%)
GE   11.56 (+0.26%)
T   37.82 (+0.59%)
PRI   130.80 (+0.27%)
BAC   33.12 (+0.85%)
DIS   148.94 (+1.39%)
S&P 500   3,108.33 (+0.15%)
DOW   27,855.44 (+0.32%)
QQQ   201.50 (-0.10%)
CGC   18.33 (-9.66%)
BABA   185.83 (+0.52%)
GE   11.56 (+0.26%)
T   37.82 (+0.59%)
PRI   130.80 (+0.27%)
BAC   33.12 (+0.85%)
DIS   148.94 (+1.39%)
S&P 500   3,108.33 (+0.15%)
DOW   27,855.44 (+0.32%)
QQQ   201.50 (-0.10%)
CGC   18.33 (-9.66%)
BABA   185.83 (+0.52%)
GE   11.56 (+0.26%)
T   37.82 (+0.59%)
PRI   130.80 (+0.27%)
BAC   33.12 (+0.85%)
DIS   148.94 (+1.39%)
S&P 500   3,108.33 (+0.15%)
DOW   27,855.44 (+0.32%)
QQQ   201.50 (-0.10%)
CGC   18.33 (-9.66%)
BABA   185.83 (+0.52%)
GE   11.56 (+0.26%)
T   37.82 (+0.59%)
PRI   130.80 (+0.27%)
BAC   33.12 (+0.85%)
DIS   148.94 (+1.39%)
Log in

PetIQ Stock Price, Forecast & Analysis (NASDAQ:PETQ)

$23.28
-0.49 (-2.06 %)
(As of 11/22/2019 01:51 PM ET)
Today's Range
$23.27
Now: $23.28
$24.02
50-Day Range
$22.71
MA: $25.24
$27.69
52-Week Range
$21.28
Now: $23.28
$36.33
Volume4,896 shs
Average Volume571,636 shs
Market Capitalization$658.13 million
P/E Ratio18.62
Dividend YieldN/A
Beta2.01
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers Rx pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and OTC medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PETQ
CUSIPN/A
Phone208-939-8900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$528.61 million
Cash Flow$1.19 per share
Book Value$11.88 per share

Profitability

Net Income$-780,000.00

Miscellaneous

Employees1,452
Market Cap$658.13 million
Next Earnings Date3/9/2020 (Estimated)
OptionableOptionable

Receive PETQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter.


PetIQ (NASDAQ:PETQ) Frequently Asked Questions

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

How were PetIQ's earnings last quarter?

PetIQ Inc (NASDAQ:PETQ) issued its quarterly earnings results on Thursday, November, 7th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.09. The company earned $186.03 million during the quarter, compared to analyst estimates of $173.21 million. PetIQ had a negative net margin of 0.59% and a positive return on equity of 9.77%. View PetIQ's Earnings History.

When is PetIQ's next earnings date?

PetIQ is scheduled to release their next quarterly earnings announcement on Monday, March 9th 2020. View Earnings Estimates for PetIQ.

What price target have analysts set for PETQ?

3 equities research analysts have issued 1 year target prices for PetIQ's stock. Their forecasts range from $35.00 to $39.00. On average, they expect PetIQ's stock price to reach $37.67 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price. View Analyst Price Targets for PetIQ.

What is the consensus analysts' recommendation for PetIQ?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.

What are Wall Street analysts saying about PetIQ stock?

Here are some recent quotes from research analysts about PetIQ stock:
  • 1. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (11/12/2019)
  • 2. Jefferies Financial Group Inc analysts commented, "PETQ remains our top small-cap growth idea post our mgmt meetings / co.’s bullish presentation at the ICR conf. in Orlando, FL. Mgmt underscored secular tailwinds in the attractive pet health industry remain very much in place, the co." (1/15/2019)

Has PetIQ been receiving favorable news coverage?

Headlines about PETQ stock have trended neutral recently, according to InfoTrie. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PetIQ earned a media sentiment score of 0.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for PetIQ.

Are investors shorting PetIQ?

PetIQ saw a decline in short interest during the month of October. As of October 31st, there was short interest totalling 4,840,000 shares, a decline of 18.4% from the September 30th total of 5,930,000 shares. Based on an average daily volume of 415,000 shares, the short-interest ratio is presently 11.7 days. Approximately 22.7% of the shares of the stock are short sold. View PetIQ's Current Options Chain.

Who are some of PetIQ's key competitors?

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), Oracle (ORCL), Nutanix (NTNX), salesforce.com (CRM), Align Technology (ALGN) and Advanced Micro Devices (AMD).

Who are PetIQ's key executives?

PetIQ's management team includes the folowing people:
  • Mr. McCord Christensen, Chairman & CEO (Age 47)
  • Ms. Susan Sholtis, Pres (Age 53)
  • Mr. John Newland, Chief Financial Officer (Age 55)
  • Mr. Robert Michael Herrman, Gen. Counsel & Sec.
  • Mr. Adam Fellers, Sr. VP of Sales

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

Who are PetIQ's major shareholders?

PetIQ's stock is owned by a number of of retail and institutional investors. Top institutional investors include TimesSquare Capital Management LLC (4.22%), Peregrine Capital Management LLC (2.37%), Russell Investments Group Ltd. (1.97%), Gabelli Funds LLC (1.11%), AMI Asset Management Corp (0.97%) and Calamos Advisors LLC (0.70%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Ronald Kennedy, Susan Sholtis and Will Santana. View Institutional Ownership Trends for PetIQ.

Which major investors are selling PetIQ stock?

PETQ stock was sold by a variety of institutional investors in the last quarter, including AMI Asset Management Corp, Nepsis Inc., North Star Investment Management Corp., Concorde Asset Management LLC, Tokio Marine Asset Management Co. Ltd., Steward Partners Investment Advisory LLC, Zurcher Kantonalbank Zurich Cantonalbank and D.A. Davidson & CO.. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mccord Christensen, Susan Sholtis and Will Santana. View Insider Buying and Selling for PetIQ.

Which major investors are buying PetIQ stock?

PETQ stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Occidental Asset Management LLC, James Investment Research Inc., Gabelli Funds LLC, California Public Employees Retirement System, Calamos Advisors LLC, Peregrine Capital Management LLC and BBVA USA Bancshares Inc.. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland and Ronald Kennedy. View Insider Buying and Selling for PetIQ.

How do I buy shares of PetIQ?

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $23.28.

How big of a company is PetIQ?

PetIQ has a market capitalization of $658.13 million and generates $528.61 million in revenue each year. The company earns $-780,000.00 in net income (profit) each year or $1.25 on an earnings per share basis. PetIQ employs 1,452 workers across the globe.View Additional Information About PetIQ.

What is PetIQ's official website?

The official website for PetIQ is http://www.petiq.com/.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]


MarketBeat Community Rating for PetIQ (NASDAQ PETQ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  259 (Vote Outperform)
Underperform Votes:  249 (Vote Underperform)
Total Votes:  508
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel